Bausch + Lomb chief executive Brent Saunders said an increasing demand for age and diabetes-related eye disease treatments will allow Bausch + Lomb's pharmaceuticals division to become the company's largest, according to a Wall Street Journal report.
The Latest
The FDA found serious problems at Ben Venue Laboratories' plant in Bedford, Ohio, according to a Businessweek report.
Yoav Medan, MD, vice president and chief systems architect at InSightec, presented the company's MR guided focused ultrasound at the 2011 TEDMED conference, according to a MedGadget report.
The Healthcare Association of New York State has released its Leading the Quest for Quality: 2011 Profiles in Quality and Patient Safety, which includes hospitals' quality improvement "success stories."
The National Quality Forum has released a new commissioned report that, among other things, evaluates how performance measures are currently being used in the healthcare field.
Cheedy Jaja, MD, at Georgia Health Sciences University is studying how gene variations that play a role in metabolizing opioids could improve pain management for sickle cell disease, according to a news release.
A new study found chronic pain is highly prevalent in children and more children suffer from pain today compared with two decades ago, according to findings published in Pain.
Leigh Montes, MD, bariatric and general surgeon, has joined the New Jersey Bariatric Center, according to a news release.
Fecal transplants have been shown to be an effective and inexpensive treatment for Clostridium difficile infection, but regulatory roadblocks prevent the treatment from becoming mainstream, according to a Wired report.
A surgical center is included in a new 20,000-square-foot facility in Houston, according to a Community Impact Newspaper report.
